12,000 Students from 15 Nations Celebrate Ryan Group’s Golden Jubilee in Mumbai
MUMBAI, India, Dec. 13, 2025 /PRNewswire/ -- Mumbai's Fine Arts Centre, came…
From ‘Make in India’ to ‘Design for India’: Ajay Piramal Charts a Vision for Nation-Building at Anant National University
AHMEDABAD, India, Dec. 12, 2025 /PRNewswire/ -- Anant National University celebrated its…
IOC receives Low Carbon Award from Geneva climate network 2050Today
11 december 2025 - In recognition of its progress in reducing its…
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
From the Capital of Capital, ADFW Charts the Next Frontier in Asset Management
ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ -- Abu Dhabi Finance Week…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
